YARROW BIOSCIENCE, INC. Revenues
YARROW BIOSCIENCE, INC. (YARW) reported Revenues of $4.29 million for the 3-month period ending 2020-12-31, per its 10-K filed 2021-03-04.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2021-03-04
- YARROW BIOSCIENCE, INC. revenues for the quarter ending 2020-12-31 was $4.29M, a 3074.81% increase year-over-year.
- YARROW BIOSCIENCE, INC. revenues for the quarter ending 2020-09-30 was $3.27M.
- YARROW BIOSCIENCE, INC. revenues for the quarter ending 2020-06-30 was $11.69M.
- YARROW BIOSCIENCE, INC. revenues for the quarter ending 2020-03-31 was $1.75M, a 468.18% increase year-over-year.
- YARROW BIOSCIENCE, INC. revenues for fiscal 2019 was $0.00.
- YARROW BIOSCIENCE, INC. revenues for fiscal 2018 was $0.00.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $4.29M 10-K · filed 2021-03-04 | $7.55M derived: sum of 2 quarters · filed 2021-03-04 | $19.24M derived: sum of 3 quarters · filed 2021-03-04 | $20.99M derived: sum of 4 quarters · filed 2021-03-04 | |
| 2020-09-30 | $3.27M 10-K · filed 2021-03-04 | $14.96M derived: sum of 2 quarters · filed 2021-03-04 | $16.71M derived: sum of 3 quarters · filed 2021-03-04 | $16.84M derived: sum of 4 quarters · filed 2021-03-04 | |
| 2020-06-30 | $11.69M 10-K · filed 2021-03-04 | $13.44M derived: sum of 2 quarters · filed 2021-03-04 | $13.57M derived: sum of 3 quarters · filed 2021-03-04 | $13.57M derived: sum of 4 quarters · filed 2021-03-04 | |
| 2020-03-31 | $1.75M 10-K · filed 2021-03-04 | $1.89M derived: sum of 2 quarters · filed 2021-03-04 | $1.89M derived: sum of 3 quarters · filed 2021-03-04 | $1.89M derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-12-31 | $135.00K 10-K · filed 2021-03-04 | $135.00K derived: sum of 2 quarters · filed 2021-03-04 | $135.00K derived: sum of 3 quarters · filed 2021-03-04 | $0.00 10-K · filed 2020-03-03 | |
| 2019-09-30 | $0.00 10-K · filed 2021-03-04 | $0.00 derived: sum of 2 quarters · filed 2021-03-04 | $0.00 10-Q · filed 2019-10-31 | $308.00K derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-06-30 | $0.00 10-K · filed 2021-03-04 | $0.00 10-Q · filed 2019-08-01 | $308.00K derived: sum of 3 quarters · filed 2021-03-04 | $308.00K derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-03-31 | $308.00K 10-K · filed 2021-03-04 | $0.00 10-Q · filed 2019-05-02 | $308.00K derived: sum of 2 quarters · filed 2021-03-04 | $308.00K derived: sum of 3 quarters · filed 2021-03-04 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 10-K · filed 2019-02-28 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | |||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |